1
Bibliografia
1. Anatomia dell’Uomo. Ambrosi E.E.
2. Piede Diabetico. Luigi Uccioli. Società Editrice Universo 2008.
3. Wild S. Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes:
estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:
1047-1053.
4. International Diabetes Federation. Diabetes Atlas, 2nd ed., 2003.
5. Cnesps - Istituto Superiore di Sanità – 2010-ISTAT.
6. Il Piede Diabetico Vol. 2 Marvin E. Levin-Lawrence W. O’Neal-John H.
Bowker. Guidotti.
7. Il diabete in Italia. Edizione Minerva Medica. Graziella Bruno Editor, 2012.
8. Il Diabete. Vol. 20. N. 1. Marzo 2008.
9. Changing Diabetes Barometer Italia. Second Report. Novo Nordisk.
10. Senato della Repubblica XVI Legislatura. Doc. XVII n. 16, 2012.
11. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., Wilson D.M., O’Brien P.C., Melton L.J., 3rd, Service F.J.: The prevalence by staged severity of various types of diabetic neuropathy , retinopathy, nefropathy, in a population-based cohort: The Rochester Diabetic Neuropathy Study.
Neurology 43: 817, 1993.
12. Veves A.: The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 35: 660, 1992.
13. Frykberg R.G., Lavery L.A., Pham H., Harvey C., Harkless L., Veves A.: Role of neuropathy and high foot pressure in diabetic foot ulceration. Diabetes Care 21: 1714, 1998.
14. International Consensus on the Diabetic Foot and practical GuideLines on the Management and Prevention of the Diabetic Foot. International Working Group on theDiabetic Foot. 2007
15. Pecoraro R.E., Reiber G.E., Burgess E.M.: Pathway to diabetic limb amputation: basis for prevention. Diabetes Care 13: 513, 1990.
16. Larsson J., Apelqvist J.: Towards less amputations in diabetic patients.
Incidence, causes, cost, tratment, and prevention- a review. Acta Orthop.
Scand.66: 181, 1995.
17. Armstrong D.G., Lavery L.A., Vela S.A., Quebedaux T.L., Fleischili J.G.:
Chosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch.Intern.Med.158: 289, 1998.
18. Peters E.J.G., Lavery L.A..: effectivness of the diabetic foot risk classification system of the international working group on the diabetic foot. Diabetes Care 24:1442, 2001.
19. Lavery A.L., Armstrong D.G., Vela S.A., Quebedeaux T.L., Fleischili J.G.:
Practical criteria for creening patients at high risk for diabetic foot ulceration.
Arch. Intern. Med. 158: 157, 1998.
20. Sosenko J.M., Kato M., Soto R., Bild D.E.:Comparison of quantitative sensory threshold measures for their association in diabetic patients. Diabetes care 13:
1057, 1990.
2 21. Young M.J., Breddy J.L., Veves A., Boulton A.J.: the prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 17: 557, 1994
22. Litzelman D.K., Marriott D.J., Vinicor F.: Indipendent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 20: 1273, 1997
23. Apelqvist J., Larsson J., Agard C.D.: The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J.Diabetes Complications 4:21, 1990.
24. Mingardi R., Lora L., Strazzabosco M., Presi S., Pasqualetti., Erle G., Uccioli L.: Fattori di rischio per ulcerazione ai piedi in un ambulatorio diabetologico:
follow-up di cinque anni. Atti XI Congresso nazionale AMD, Montecatini Terme, 28-31 Maggio, 1997, p.475.
25. Mueller M.J.: Therapeutic footwear helps protect the diabetic foot. J.
Am.Podiatr.Med.Assoc.87:360, 1997.
26. Lavery L.A., Vela S.A., Fleischili J.G., Armstrong D.G., Lavery D.C.: Reducing plantar pressure in the neuropathic foot. A comparison of footwear. Diabetes Care 20: 1706, 1997.
27. Brand P.W.: repetitive stress in the development of diabetic foot ulcers. In:
Levin M.E., Davidson J.K., The diabetic foot, ed. 4. Mosby, St.Louis, 1988, p.83.
28. Veves A.: The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 35: 660, 1992.
29. Litzelman D.K., Marriot D.J., Vinicor F.: The role of footwear in the prevention of foot lesions in patients with NIDDM. Diabetes Care 20: 156, 1997.
30. Uccioli L., Faglia E., Monticone G., Faveles F., Durola L., Aldeghi A., Quarantiello A., Calia P., Menzinger G.: Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 18: 1376, 1995.
31. Caselli A., Toffolo M., Volpi A., Pasqualetti P., Menziger G., Uccioli L.:
Efficacia dell’ uso di differenti scarpe e plantari nel ridurre il sovraccarico pressorio plantare in pazienti neuropatici. Atti XVII Congresso Nazionale Società Italiana di Diabetologia, Bologna, 13-16 Maggio 1998.
32. Chantelau E., Haage P.: An audit of cushioned diabetic footwear; relation to patient compliance. Diabet. Med. 11:114, 1994.
33. Veves A., Sarnow M.R..: Diagnosis classification and treatment of diabetic peripheral neuropathy. Clin.Podiatr.Med.Surg 12: 19-30, 1995.
34. American Diabetes Association, American Accademy of Neurology: Report and recommendation of the San Antonio Conference on Diabetic Neuropathy.
Diabetes Care 11: 592, 1998.
35. Lardieri L., et al. : The risk of foot ulceration : correspondence between different classification system. Riunione del Diabetic Foot Study Group, 7-9 Settembre 2001 (Abstract Book).
36. Meijer J.W., van Sonderen E., Blaauwwiekel E.E., Smith A.J., Groothoff J.W., Eisma W.H., Links T.P.: Diabetic Neuropathy Examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 23: 750, 2000.
37. Comprehensive Foot Examination and Risk Assessment.A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of clinical endocrinologists.
Boulton A, Armstrong D.G., Stephen F., Frykberg R..Diabetes Care , volume 31, Numebr 8, August 2008.
3 38. Boulton A.J., Kubrusly D.B., Bowker J.H., Gadia M.T., Quintero L., Becker D.M., Skyler J.S., Sosenko J.M.: Impaired vibratory perception and diabetic foot ulceration. Diabet. Med. 3: 335, 1986.
39. Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC:
Reevaluating how we classify the diabetic foot: reconstructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot.Diabetes Care 31:154-156,2008.
40. Pell J.P., Fowkes F.G.R.: Epidemiology of critical limb ischaemia. Critical Ischaemia 2:3, 1992.
41. Shanahan CM, Cary NRB, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Mediale Localization of mineralization-regulating proteins in association with MOnckeberg’s sclerosisi: evidence for smooth muscle cell- mediated vascular calcification. Circulation 1999;100:2168-2176.
42. European Working Group Leg Ischemia: Second European consensus document on chronic critical leg ischemia. Eur.J.Vasc.Surg.6(Suppl A): 1, 1992.
43. Faglia E., Favales F., Quarantiello A., Calia P., Brambilla G., Rampoldi A., Morabito A.: feasibility and effectivness of peripheral percutaneos transluminal balloon angioplasty in diabetic subjects with foot ulcers. Diabetes Care 19:
1261, 1996.
44. Ouriel K.: peripheral arterial disease. Lancet 358: 1257, 2001
45. Faglia E., Favales F., Aldeghi A., Calia P., Quarantiello A., Barbano P., Puttini M., Palmieri B., Brambilla G., Rampoldi A., Mazzola E., Valenti L., Fattori G., Rega V., Cristalli A., Oriani G., Micheal M., Morabito A.: Change in major amputation rate in a Center dedicated to diabetic foot care during tha 1980s:
prognostic determinants for major amputation. J. Diabetes complications 12:
96, 1998.
46. Criqui M, Denenberg J, Langer R.The epidemiology of peripheral arterial disease : importance of identifying the population at risk.Vasc Med 1997.
47. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) : a collaborative report from the American Association for vascular Surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology and the ACC/AHA task force on practice guidelines.J Am Coll Cardiol 2006 ;6 :1239- 1312.
48. Murray H.J., Boulton A.J.M.: The pathophysiology of diabetic foot ulceration.
Clin. Podiatr. Med. Surg. 12: 1, 1995.
49. Eckman M.H., Greenfield S., Mackey W.C., Wong J.B., Kaplan S., Sullivan L., Dukes K., Pauker S.G.: Foot infections in diabetic patients: decision and cost- effective analyses. J.A.M.A. 273: 712, 1995.
50. L.Prompers, N.Shaper, J.Apelqvist, M.Edmonds, E.Jude, D.Mauricio, L.Uccioli, V.Urbancic, K.Bakker, P.Holstein, A.Jirkovska, A.PIaggesi,
G.Ragnarson, H.Reike, M.Spraul, K. Van Acker, J Van Baal, F. Van Merode, I.Ferriera, M.Huijberts. Predicition of out come in individuals with diabetic foot
4 ulcer: focus on the differences between individuals with and without
peripheral arterial disease. THE EURODIALE Study. Diabetologia 2008.
51. Gibbons G.W., Eliopolous G.M.: Infections of the diabetic foot. In: Kozac G.P., Hoar C.S., Jr., Rowbotham R.L., et al.(Eds), Management of diabetic foot problems. W.B. Saunders, Philadelphia, 1984, p. 97.
52. Eneroth M., Apelqvist J., Stenstrom A.: Clinical characteristics and outcome in 223 diabetic patients with deep foot infections.
53. S. NUTI (2008), La valutazione come metodo di lavoro: il sistema adottato dalla Regione Toscana , Monitor , pp. 87-108, Total pages: 22 Vol. 1 n. 1.
54. S.Nuti, C.Seghieri, M.Vainieri (2012), Assessing the effectiveness of a performance evaluation system in the public health care sector: some novel evidence from the Tuscany Region experience. , The Journal Of Management And Governance
55. Il sistema di valutazione della performance della sanità toscana. Report 2009- 2012. MeS.
56. Katz S., Klein B., Elian I., Fishman P., Djaldetti M.: Phagocyte activity of monocytes from diabetic patients. Diabetes Care 6: 479, 1983.
57. Lavery L.A., Armstrong D.G., Harkless L.B.: Classification of diabetic foot wounds. J.Foot Ankle Surg.35. 528, 1996.
58. Armstrong DG, Frykber G.Classifying diabetic foot surgery : toward a rational definition.Diab.med 20, 329-331 .2003
59. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, NOrden C, Tan JS.Diagnosis and treatment of the diabetic foot infections.Clin Infect Dis 39 : 885—910, 2004.
60. Piaggesi A., Schipani E., Campi F., Romanelli M., Baccetti F., Arvia C., Navalesi R.: Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet.Med.15: 412, 1998.
61. Piaggesi A., Goretti C., Mazzurco S., Tedeschi A., Leonidli A., Tascini C., Rizzo L., Del Prato S. A randomized controlled trial to examine the efficacy andsafety of a new superoxided solution for the management of wide postsurgical lesions of the diabetic foot”. Int J low Extrem Wounds,2010 Mar;9(1):10-5.
62. Reducing Amputations in “at risk foot”.Editorial-Indian J Med Res 122, 14 November 2005.
63. N.Singh,AG Armastrong, Lipksy B, .Preventing foot ulcers in patients with diabetes.Jama 2005
64. Manifesto dei diritti della persona con diabete. Dawn. Associazione Diabete in Italia. 2009.
65. V. Sierma, H. Thorsen, P.E. Holstein, M. Kars, J. Apelqvist, E.B. Jude, A.
Piaggesi, K. Bakker, M. Edmond, A. Jirkovska, D. Mauricio, G. Ragnarson Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbancic, K. Van Acker, J. Van Baal and N. C. Schaper: Short Report: Care Delivery. Importance of factors
5 determining the low health-related quality of life in people presentino with a diabetic foot ulcer:the Eurodiale study. Diabetic Medicine 2013.
